| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/08/2013 | EP2588866A1 Diagnosis and treatment of brain tumors |
| 05/08/2013 | EP2588865A1 The role of fragile x mental retardation gene and protein in cancer metastasis |
| 05/08/2013 | EP2588499A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 05/08/2013 | EP2588498A1 Llt-1 antibodies with new functional properties |
| 05/08/2013 | EP2588211A2 Env trimer immunogens |
| 05/08/2013 | EP2588141A2 Antibody formulations |
| 05/08/2013 | EP2588138A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 05/08/2013 | EP2588137A1 Fimh vaccine against urinary tract infections (uti) |
| 05/08/2013 | EP2588136A2 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1 |
| 05/08/2013 | EP2588135A2 Nanoemulsion vaccines |
| 05/08/2013 | EP2588134A1 Diagnostic assay for type 1 diabetes |
| 05/08/2013 | EP2588133A2 Vaccine against ehrlichia canis and associated methods |
| 05/08/2013 | EP2588120A2 Compositions and methods related to protein a (spa) variants |
| 05/08/2013 | EP2588118A1 Constrained immunogenic compositions and uses therefor |
| 05/08/2013 | EP2588107A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| 05/08/2013 | EP2340851A9 Diagnosis method and therapeutic method for cancer |
| 05/08/2013 | DE112011102397T5 Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie A pharmaceutical combination compositions and methods for treating vertigo, motion sickness and vegetative-vascular dystonia |
| 05/08/2013 | CN1798768B Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 05/08/2013 | CN103097416A Humanized IL-25 antibodies |
| 05/08/2013 | CN103097415A Humanised antigen binding proteins to myostatin6 |
| 05/08/2013 | CN103097410A Improved antibodies of the class IgG4 |
| 05/08/2013 | CN103097399A Compositions and methods for the removal of biofilms |
| 05/08/2013 | CN103097386A Lipidated immune response modifier compound compositions, formulations, and methods |
| 05/08/2013 | CN103096927A Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 05/08/2013 | CN103096926A Combination therapy of an afucosylated CD20 antibody with an anti- VEGF antibody |
| 05/08/2013 | CN103096925A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases |
| 05/08/2013 | CN103096924A Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| 05/08/2013 | CN103096923A Novel immunoadjuvant compounds and uses thereof |
| 05/08/2013 | CN103096922A Compositions and methods for treating influenza |
| 05/08/2013 | CN103096921A Concentration of vaccine antigens without lyophilization |
| 05/08/2013 | CN103096920A Non-lipidated variants of neisseria meningitidis ORF2086 antigens |
| 05/08/2013 | CN103096919A Method of vaccination |
| 05/08/2013 | CN103096914A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| 05/08/2013 | CN103096913A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
| 05/08/2013 | CN103096912A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| 05/08/2013 | CN103096911A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 05/08/2013 | CN103096910A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
| 05/08/2013 | CN103096875A Biodegradable lipids for the delivery of active agents |
| 05/08/2013 | CN103088063A Recombinant pseudotype baculovirus expressing rabies virus G protein and application |
| 05/08/2013 | CN103088049A DNA (Deoxyribose Nucleic Acid)-based infectious clone of a Japanese encephalitis virus SA14-14-2 strain, as well as construction method and application thereof |
| 05/08/2013 | CN103088038A Flavivirus vaccine |
| 05/08/2013 | CN103087996A Recombinant porcine reproductive and respiratory syndrome virus as well as preparation method and application thereof |
| 05/08/2013 | CN103087994A Coxsackievirus A16-type virus strain and use thereof |
| 05/08/2013 | CN103087198A MRSA (Methicillin Resistant Staphylococcus Aureus) vaccine recombinant protein antigen I1C and preparation method and application thereof |
| 05/08/2013 | CN103087194A Anti-blood-cycle-venin egg yolk antibody and application thereof |
| 05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
| 05/08/2013 | CN103087190A Anti-gm-csf antibodies and uses therefor |
| 05/08/2013 | CN103087188A Immunoglobulin fraction and process therefor |
| 05/08/2013 | CN103087173A Synthetic peptide vaccine of B cell epitope based on TGF(transforming growth factor)-beta1 and application thereof |
| 05/08/2013 | CN103087156A Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine |
| 05/08/2013 | CN103087155A Rabies virus vaccine enhancin, gene for coding enhancin and application of enhancin |
| 05/08/2013 | CN103083684A Method for improving immune protective rate of fasciola hepatica Cat L1 (FhCat L1) DNA (Deoxyribose Nucleic Acid) vaccine |
| 05/08/2013 | CN103083665A Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens |
| 05/08/2013 | CN103083664A Puer tea immune adjuvant and application thereof in influenza vaccines |
| 05/08/2013 | CN103083663A Immunity enhancing agent, inactivated vaccine, and preparation method thereof |
| 05/08/2013 | CN103083662A Preparation and application of wild buckwheat rhizome superfine powder |
| 05/08/2013 | CN103083661A Application of carbon nanotube in preparation of immunostimulant of anti-tumor immunotherapy medicine |
| 05/08/2013 | CN103083660A Immunologic adjuvant for preventing toxoplasma infection and application of immunologic adjuvant |
| 05/08/2013 | CN103083659A Preparation method and application of novel oil-free adjuvant |
| 05/08/2013 | CN103083658A Vaccine adjuvant composition for treatment or prevention of swine infectious diseases |
| 05/08/2013 | CN103083657A Immunogenic composition |
| 05/08/2013 | CN103083656A Conjugate of influenza A virus conservative peptides M2e and virus-like particles, and application thereof |
| 05/08/2013 | CN103083655A Vaccine composition for preventing and treating porcine circovirus type 2, haemophilus parasuis and mycoplasma hyopneumoniae infection and preparation method thereof |
| 05/08/2013 | CN103083654A Process for preparing human diploid cell rabies vaccine through Celligen310 bioreactor |
| 05/08/2013 | CN103083653A Method for producing classical swine fever live vaccine by using microcarrier high-density cell culture technology |
| 05/08/2013 | CN103083652A Meningococcal polysaccharide conjugate vaccine treating heterobifunctional reagent as conjugation bridge, and its preparation method |
| 05/08/2013 | CN103083238A Taraxacum tibetanum polysaccharide nanoemulsion and preparation method thereof |
| 05/08/2013 | CN102397540B Recombinant phage vaccine for avian influenza A and construction method for recombinant phage vaccine |
| 05/08/2013 | CN102327603B Preparation method and use method of loach aeromonas sobria vaccine |
| 05/08/2013 | CN102286101B Fab (fragment of antigen binding) fragment Vasculizumab of anti-VEGF (vascular endothelial growth factor) monoclonal antibody and application thereof |
| 05/08/2013 | CN102276722B Novel vascular endothelial growth factor humanized monoclonal antibody |
| 05/08/2013 | CN102233136B Recombinant plasmid vaccine for treating hepatitis B and composition thereof |
| 05/08/2013 | CN102212131B Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/08/2013 | CN102210858B Combined EV71 (enterovirus 71)-HA (hepatitis A) vaccine |
| 05/08/2013 | CN102206607B Three genes deleted mutant of enterohemorrhagic escherichia coli O157:H7 |
| 05/08/2013 | CN102139100B Application of protein Mip in immune protection of coxiella burnetii |
| 05/08/2013 | CN102120029B Preparation method of alginate microparticles capable of inducing tumor immune response |
| 05/08/2013 | CN102060925B Interleukin-13 antibody composition |
| 05/08/2013 | CN101703769B Novel tetravalent inactivated vaccine for streptococcus suis disease |
| 05/08/2013 | CN101693885B Anti-HBV (hepatitis B Virus) nicotine medicine composition |
| 05/08/2013 | CN101616930B Method of purification of hydrophobic proteins |
| 05/08/2013 | CN101400703B Domain antibody construct |
| 05/08/2013 | CN101356274B Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
| 05/08/2013 | CN101282984B Immunogens for meningitidis-a vaccines |
| 05/08/2013 | CN101163503B Extending time to disease progression or survival in cancer patients using her dimerization inhibitor |
| 05/08/2013 | CN101141979B Cat allergen conjugates and uses thereof |
| 05/08/2013 | CN101115766B Codon-optimized HPV16LI for salmonella vaccine strains against human papillomavirus type 16 |
| 05/07/2013 | US8436150 Humanized C-kit antibody |
| 05/07/2013 | US8436146 Therapeutic use of anti-CS1 antibodies |
| 05/07/2013 | US8436139 Apo-lipoprotein B fragment for use in prevention and treatment of cardiovascular and ischemic disorders |
| 05/07/2013 | US8435961 Methods and compositions for increasing the activity of inhibitory RNA |
| 05/07/2013 | US8435952 Method for retarding progression to definite rheumatoid arthritis in subjects with undifferentiated arthritis |
| 05/07/2013 | US8435948 Follicle stimulating hormone (Fsh); bioavailability; drug screening |
| 05/07/2013 | US8435801 Methods and compositions for the production of monoclonal antibodies |
| 05/07/2013 | US8435784 Cryopreservation of haptenized tumor cells |
| 05/07/2013 | US8435749 Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 05/07/2013 | US8435731 Markers for viral infections and other inflammatory responses |
| 05/07/2013 | US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 05/07/2013 | US8435539 Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| 05/07/2013 | US8435538 Anti-atheroma vaccine |